A Randomized, Double-Masked, Active-Controlled, Crossover Phase III Equivalence Study of Generic Dorzolamide 2% versus Innovator Trusopt® Eye Drop Solution in Subjects with Open-Angle Glaucoma or Ocular Hypertension

BACKGROUND: The aim of this study was to demonstrate the equivalence of generic dorzolamide 2% eye drops solution versus the innovator formulation (Trusopt® eye drops solution) in patients with open-angle glaucoma or ocular hypertension. METHODS: This prospective, monocentric, double-masked, active-...

Descripción completa

Detalles Bibliográficos
Autores principales: Bell, Katharina, Korb, Christina, Butsch, Christina, Giers, Bert Constantin, Beck, Anna, Strzalkowska, Alicja, Ruckes, Christian, Klingberg, Ulrike, Pfeiffer, Norbert, Lorenz, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329021/
https://www.ncbi.nlm.nih.gov/pubmed/35909461
http://dx.doi.org/10.1155/2022/5249922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9329021/
https://www.ncbi.nlm.nih.gov/pubmed/35909461
http://dx.doi.org/10.1155/2022/5249922

Ejemplares similares